Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Central venous access is a core skill for anesthesiologists, intensivists, acute care physicians, and surgeons. It is indicated for fluid and drug administration, dialysis, and cardiovascular monitoring. More than 5 million central venous catheters (CVCs) are inserted annually in the United States. Because central venous access often remains poorly taught and left out of training curricula, inexperienced and less skilled practitioners frequently experience significant difficulties.
Ultrasound guidance (USG) for CVC placement was introduced in the 1980s. Since then, many reports have demonstrated increased success, enhanced safety, and effectiveness of USG in comparison to anatomic landmark or audio Doppler-based techniques.
Several national and international recommendations have been developed that advocate the routine use of USG for placement of CVCs. Although the original practice guidelines focused mainly on USG for cannulation of the internal jugular vein (IJV), USG can be used at most sites.
The first part of this chapter reviews the basics of USG, whereas the rest of the chapter focuses on specific access sites and current recommendations.
To appreciate the importance of ultrasound-guided vascular access (USGVA) it is necessary to understand the potential complications of attempted vascular access, which can be grouped under immediate and delayed complications. The former include inadvertent arterial or venous puncture and cannulation, hematoma, posterior vessel wall (through-and-through) puncture, pneumothorax or hemothorax, and air embolism. Other complications include multiple skin punctures, patient anxiety and discomfort, and failure of the procedure. Thoracic duct injury and nerve injury may follow CVC placement. Late complications of vascular access are local and distant infection, including catheter-related bloodstream infection (CRBSI), arterial or venous thrombosis, vessel stenosis, occlusion of the lumen or device, arteriovenous fistula formation, and tip migration. ,
USGVA can potentially reduce the incidence or completely prevent many of these complications and improve the safety of the procedure. This is due to a reduction or avoidance of primary damage caused by injury to collateral structures from the needle or secondary damage caused by misplaced guidewires, dilators, and catheters. USG enables direct visualization of the vessel or vessels of interest and surrounding structures. The depth and size of the target vessel can be measured and an optimal target vessel and site for venipuncture chosen. In trained hands, USGVA reduces the frequency of unsuccessful punctures and associated complications and facilitates first-pass cannulation. A preprocedural scan is performed to identify abnormal anatomy, thrombosis, or valves, and a postcannulation scan is used to confirm correct placement of the guidewire and catheter in the intended vessel. Ultrasound can be used reliably for the diagnosis of pneumothorax or pleural fluid collections. The same transducer used for cannulation can be used to examine the pleura. There is a potential reduction in CRBSI when USGVA is integrated within a multifaceted strategy. USGVA is cost-effective because of better clinical outcomes and reduced cost of care. , ,
Application of electric current to the piezoelectric element in the transducer creates ultrasound waves (see Chapter 1 ). The mechanical energy generated travels and penetrates through the tissues as pulsed longitudinal waves, some of which will be absorbed or lost in the tissues whereas the remainder will be reflected back at different tissue interfaces and received at the transducer. The phenomenon of attenuation describes the loss of ultrasound energy via absorption, reflection, refraction, and scattering and can cause distortion of the image and misinterpretation of anatomic relationship. The returned energy is processed into an anatomic representation of the underlying structures (see Chapter 1 ).
Broad-frequency transducers (5 to 15 MHz) are typically used for vascular access. Higher frequencies provide better resolution, are best suited for superficial structures, and enable identification and avoidance of adjacent vulnerable structures (e.g., small arteries and nerves). High resolution is also required for neonatal and pediatric cannulation. ,
Midrange frequencies (5 to 10 MHz) are used to visualize structures 3 to 6 cm under the surface of the skin. A low-frequency probe operates below 5 MHz and is usually reserved for deeper structures; it is not commonly used for vascular access. ,
The scanning surface (footprint) may be linear or curvilinear. Typical footprints vary from 20 to 50 mm in length. Smaller footprints enable access to confined anatomic locations (e.g., infraclavicular imaging or children), whereas large footprints allow the acquisition of a wider image. ,
Safe, successful vascular access requires attention to the surrounding environment: ultrasound display position and transducer orientation. Operator experience and patient and equipment factors contribute to the final outcome. Adequate knowledge of the physics of USG and the mechanism of image acquisition and interpretation is essential before attempting USGVA. The operator must have the ability to interpret the displayed two-dimensional (2D) image of the vessels of interest and associated tissues, use this 2D image to perform a three-dimensional (3D) task, and possess the necessary hand-eye coordination and manual dexterity skills to manipulate the needle and transducer according to the displayed image.
The display should be positioned at an appropriate height for the procedure and on the contralateral side of the patient. , The displayed image should be in the same anatomic orientation as seen from the position of the practitioner. A palpable marker on the side of the transducer corresponds to an orientation cue on the display. Touching one end of the probe and observing the associated display artifact will eliminate confusion.
Typically, the operator holds the ultrasound probe with the nondominant hand in such a way that the structures beneath the left end of the probe appears on the left side of the screen and vice versa, and subsequently each side of the screen will display the ipsilateral structures. ,
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here